Avenue Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -2,701 | -3,708 | 2,736 |
EBIT | -2,823 | -7,416 | 617 |
Net Income | -7,186 | -4,340 | 640 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,253 | -3,120 | 676 |
Cash | 4,919 | 3,194 | 1,783 |
Basic Shares | 1,117 | 562 | 25,597 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | 4,052 | -8,023 | -3,731 | -5,213 |
EBIT | -10,488 | -16,066 | -3,738 | -5,213 |
Net Income | -10,377 | 2,048 | -3,724 | -5,089 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -5,613 | |||
Free Cash Flow | -12,451 | -7,596 | -3,750 | -5,613 |
Cash | 1,783 | 6,708 | 3,763 | 3,132 |
Basic Shares | 141 | 2,185 | 1,133 | 1,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.92 |
2024-06-30 | -$6.43 |
2024-03-31 | -$15.40 |
2023-12-31 | $0.06 |
